No Picture
San Diego Biotech Jobs

Research Associate: Organic Chemistry and Purification – Debut Biotechnology Inc – San Diego, CA

Debut Biotechnology is seeking a senior research associate to aid in downstream processing to support the purification and isolation of small molecules produced… $60,000 – $75,000 a yearFrom Indeed – Tue, 11 Jan 2022 21:05:37 GMT – View all San Diego, … […]

No Picture
San Diego Biotech Jobs

Research Associate: Organic Chemistry and Purification – Debut Biotechnology Inc – San Diego, CA

Motivated by a sense of urgency, attention to detail, and an engrained penchant for professional development of themselves and their co-worker. $60,000 – $75,000 a yearFrom Indeed – Tue, 11 Jan 2022 21:05:37 GMT – […]

No Picture
San Diego Biotech Jobs

Scientist – Research & Development Biomarker Discovery – DermTech – La Jolla, CA

One centered around our patented methods, which begins with using our Smart StickerTM to collect tissue from the skin’s surface easily, accurately, and… $90,000 – $130,000 a yearFrom Indeed – Tue, 11 Jan 2022 19:22:49 GMT – View all La Jolla, CA jobs […]

No Picture
News

Scientists Expand CRISPR-Cas9 Genetic Inheritance Control in Mammals

UC San Diego biologists have developed a method for genetic inheritance control in male mice, an achievement that advances new laboratory models in an array of research pursuits, from investigations of human disease to therapeutic drug design to invasive species removal. Click here to view original post… […]

No Picture
San Diego Biotech Jobs

Regional Account Manager, Biotech – Southwest – Nova Biomedical – San Diego, CA

Minimum of 3-5 years of documented success in capital instrumentation sales in the Biologics market. Highlights of benefits offered to Nova Biomedical employees…From Nova Biomedical – Tue, 11 Jan 2022 18:04:00 GMT – View all San Diego, CA jobsClick here to view original post… […]

No Picture
News

Phanes Therapeutics announces the appointment of Vice President of Business Development

SAN DIEGO: SAN DIEGO, Jan. 11, 2022 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has appointed Mr. Paul Chu, MBA, as Vice President of Business Development. "We welcome Paul to the Phanes family and are delighted to appoint… Click here to view original post… […]

No Picture
News

Plants rely on the CLASSY gene family to diversify their epigenomes

LA JOLLA—What determines how a cell’s genome is regulated to ensure proper growth and development? Turns out, the parts of the genome that are turned on or off in each cell-type or tissue play a major role in this process. Now, a team at Salk has shown that the CLASSY… Click here to view original post… […]

No Picture
San Diego Biotech Jobs

Manufacturing Lead Operator – Night Shift – Thermo Fisher Scientific – Carlsbad, CA

Bachelor's Degree in Life Sciences, Engineering, or Biotechnology or certificate program and two to four years biotech or pharmaceutical related experience.From Thermo Fisher Scientific – Tue, 11 Jan 2022 16:16:32 GMT – View all Carlsbad, CA jobsClick here to view original post… […]

No Picture
News

Polynoma Receives Special Protocol Assessment (SPA) Agreement from the U.S. FDA for a Pivotal Phase 3 Clinical Study of Seviprotimut-L, a Melanoma Cancer Vaccine

SAN DIEGO: SAN DIEGO, Jan. 11, 2022 /PRNewswire/ — Polynoma LLC, a U.S. immuno-oncology focused biopharmaceutical company and wholly-owned subsidiary of Hong Kong-listed CK Life Sciences Int’l., (Holdings) Inc., today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment… Click here to view original post… […]

No Picture
News

Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs

SAN DIEGO: SAN DIEGO, Jan. 11, 2022 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need including KRAS-mutated colorectal cancer, pancreatic cancer, and castrate-resistant prostate cancer, today announced the appointments of… Click here to view original post… […]

No Picture
News

Oncolytics Biotech® Releases a Letter to Shareholders – 2021 Review and 2022 Outlook

SAN DIEGO, Calif. and CALGARY, AB: SAN DIEGO, Calif. and CALGARY, AB, Jan. 11, 2022 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) is providing a letter to shareholders, included below. To the Shareholders of Oncolytics Biotech, 2021 generated ground-breaking data that creates the foundation for continued success in… Click here to view original post… […]